FDA performance goals for approving drugs and biologics

JAMA. 2009 Jul 8;302(2):189-91. doi: 10.1001/jama.2009.974.

Author

James Dabney Miller¹

Affiliation

¹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 4110 Greenway, Baltimore, MD 21218, USA. jdmiller@jhsph.edu

PMID: 19584348
DOI: 10.1001/jama.2009.974

No abstract available

MeSH terms

Budgets
Drug Approval / organization & administration*
Drug Industry / economics
Financing, Government / legislation & jurisprudence*
Health Policy
Legislation, Drug
Management Audit
Politics
United States
United States Food and Drug Administration / economics*
United States Food and Drug Administration / standards*